Thrombolysis
Return to Library
|
Free Thrombolysis Articles |
|
|
|
|
Studies from University of California in the area of heart attack published
2009 JUL 27 - (NewsRx.com) -- According to a study from the United States, "Acute myocardial infarction resulting from saphenous vein graft occlusion occurs not infrequently in patients who have undergone coronary artery bypass graft surgery. In this case report, we present a novel case of spontaneous recanalization of a thrombotic graft occlusion in a patient who presented with a subacute myocardial infarction." "The patient was treated medically with aspirin as the only anti-platelet agent. Interestingly, he presented 2 months later with new onset angina. Coronary angiography demonstrated complete resolution of thrombus but a severe focal stenosis in the distal anastomoses," wrote P.P. Hu and colleagues, University of California. The researchers concluded: "Following drug eluting stent placement, a favorable clinical course has ensued and patency confirmed on follow up angiography at 1 year." Hu and colleagues published the results of their research in the Journal of Thrombosis and Thrombolysis (Spontaneous recanalization of a completely occluded saphenous vein graft two months following acute myocardial infarction with persistent one year patency. Journal of Thrombosis and Thrombolysis, 2009;28(1):101-105). For additional information, contact S. Tsimikas, University of California, Vascular Medicine Program, 9500 Gilman Dr., BSB 1080, La Jolla, CA 92093, USA. The publisher of the Journal of Thrombosis and Thrombolysis can be contacted at: Springer, Van Godewijckstraat 30, 3311 Gz Dordrecht, Netherlands. Keywords: United States, La Jolla, Angiology, Angioplasty, Cardiology, Coronary Artery Bypass Graft, Coronary Artery Disease, Coronary Disease, Drug Development, Fibrinolysis, Heart Attack, Heart Bypass Surgery, Heart Disease, Hematology, Medical Device, Myocardial Infarction, Pharmaceuticals, Saphenous Vein, Surgery, Surgical Technology, Therapy, Thrombolysis, Thrombosis, Treatment, Vein Graft, University of California. This article was prepared by Biotech Business Week editors from staff and other reports. Copyright 2009, Biotech Business Week via NewsRx.com.
|
